Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the fourth leading cause of cancer-related death worldwide. Sorafenib is currently acknowledged as a standard therapy for advanced HCC. However, acquired resistance substantially limits the clinical efficacy of sorafe...

Full description

Bibliographic Details
Main Authors: Chen, Y. (Author), Hou, X. (Author), Huang, X. (Author), Li, D. (Author), Moorhead, J.F (Author), Rao, Y. (Author), Ruan, X.Z (Author), Su, Y. (Author), Varghese, Z. (Author), Wei, L. (Author), Yao, Y. (Author), You, Z. (Author), Zheng, G. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher